JP2010534684A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534684A5 JP2010534684A5 JP2010518431A JP2010518431A JP2010534684A5 JP 2010534684 A5 JP2010534684 A5 JP 2010534684A5 JP 2010518431 A JP2010518431 A JP 2010518431A JP 2010518431 A JP2010518431 A JP 2010518431A JP 2010534684 A5 JP2010534684 A5 JP 2010534684A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition according
- amino acid
- acid sequence
- cationic peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 125000002091 cationic group Chemical group 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95205907P | 2007-07-26 | 2007-07-26 | |
| US60/952,059 | 2007-07-26 | ||
| PCT/US2008/071350 WO2009015385A1 (en) | 2007-07-26 | 2008-07-28 | Antimicrobial peptide, compositions , and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013222846A Division JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010534684A JP2010534684A (ja) | 2010-11-11 |
| JP2010534684A5 true JP2010534684A5 (esLanguage) | 2011-06-02 |
| JP5401457B2 JP5401457B2 (ja) | 2014-01-29 |
Family
ID=40281862
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518431A Expired - Fee Related JP5401457B2 (ja) | 2007-07-26 | 2008-07-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2013222846A Expired - Fee Related JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2016132290A Pending JP2017002057A (ja) | 2007-07-26 | 2016-07-04 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2018153719A Active JP6722241B2 (ja) | 2007-07-26 | 2018-08-17 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2020105975A Pending JP2020169190A (ja) | 2007-07-26 | 2020-06-19 | 抗菌ペプチド、組成物及びその使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013222846A Expired - Fee Related JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2016132290A Pending JP2017002057A (ja) | 2007-07-26 | 2016-07-04 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2018153719A Active JP6722241B2 (ja) | 2007-07-26 | 2018-08-17 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2020105975A Pending JP2020169190A (ja) | 2007-07-26 | 2020-06-19 | 抗菌ペプチド、組成物及びその使用方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8623811B2 (esLanguage) |
| EP (3) | EP2178549B1 (esLanguage) |
| JP (5) | JP5401457B2 (esLanguage) |
| KR (4) | KR101717275B1 (esLanguage) |
| CN (2) | CN102872447B (esLanguage) |
| AU (1) | AU2008278593B2 (esLanguage) |
| BR (3) | BR122019000266B1 (esLanguage) |
| CA (1) | CA2694046C (esLanguage) |
| CO (1) | CO6260098A2 (esLanguage) |
| CR (1) | CR11239A (esLanguage) |
| CY (2) | CY1118503T1 (esLanguage) |
| DK (2) | DK2178549T3 (esLanguage) |
| ES (2) | ES2609914T3 (esLanguage) |
| HR (1) | HRP20161722T1 (esLanguage) |
| HU (1) | HUE031136T2 (esLanguage) |
| IL (3) | IL203173A (esLanguage) |
| LT (1) | LT2178549T (esLanguage) |
| MX (1) | MX2010000916A (esLanguage) |
| NZ (1) | NZ582459A (esLanguage) |
| PL (1) | PL2178549T3 (esLanguage) |
| PT (2) | PT2178549T (esLanguage) |
| SG (1) | SG188128A1 (esLanguage) |
| SI (1) | SI2178549T1 (esLanguage) |
| WO (1) | WO2009015385A1 (esLanguage) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ598159A (en) * | 2006-12-29 | 2013-08-30 | Revance Therapeutics Inc | Transport molecules using reverse sequence hiv-tat polypeptides |
| DK2178549T3 (en) * | 2007-07-26 | 2017-01-09 | Revance Therapeutics Inc | Antimicrobial peptide AND COMPOSITIONS THEREOF |
| US8080518B2 (en) * | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| MY155049A (en) | 2008-03-14 | 2015-08-28 | Allergan Inc | Immuno-based botolinum toxin serotype a activity assay |
| LT2379104T (lt) * | 2008-12-31 | 2018-04-10 | Revance Therapeutics, Inc. | Injekcinės botulino toksino vaisto formos |
| MX2011010335A (es) * | 2009-04-01 | 2012-01-12 | Revance Therapeutics Inc | Metodos y composiciones para tratar afecciones de la piel asociadas con hiperreactividad vascular. |
| PT2440231T (pt) | 2009-06-10 | 2020-01-08 | Nono Inc | Co-administração de um agente ligado a um peptido de internalização tat com um inibidor de desgranulação de mastócitos |
| CN102869373B (zh) * | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
| US10022083B2 (en) | 2011-06-02 | 2018-07-17 | Abdulmohsen E. A. H. Al-Terki | Multiple oral and nasal surgical procedures method and kit |
| US8387798B1 (en) | 2012-04-27 | 2013-03-05 | Abdulmohsen E. A. H. Al-Terki | Mutiple oral and nasal surgical procedures method and kit |
| FR2997304B1 (fr) | 2012-10-26 | 2017-07-07 | Isp Investments Inc | Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens |
| WO2014066916A2 (en) | 2012-10-28 | 2014-05-01 | Revance Therapeutics, Inc. | Compositions and methods for safe treatment of rhinitis |
| US20140242110A1 (en) * | 2013-02-28 | 2014-08-28 | Dt Scimed, Llc | Dose, localization, and formulation of botulinum toxins in skin and muscle |
| US11484580B2 (en) | 2014-07-18 | 2022-11-01 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
| US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US11446236B2 (en) | 2015-08-05 | 2022-09-20 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
| ES2934714T3 (es) * | 2015-09-17 | 2023-02-24 | Contrafect Corp | Polipéptidos de lisina activos contra bacterias Gram-negativas |
| US10105381B2 (en) * | 2016-05-23 | 2018-10-23 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US10144767B2 (en) * | 2016-08-18 | 2018-12-04 | Board Of Regents Of The University Of Nebraska | Anti-microbial peptides and coatings |
| EP3541358A1 (en) * | 2016-11-21 | 2019-09-25 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| EP3675900A4 (en) | 2017-08-28 | 2021-05-05 | Revance Therapeutics, Inc. | Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders |
| CN107556374B (zh) * | 2017-08-30 | 2020-02-07 | 四川大学 | 唾液富脯蛋白仿生防龋功能多肽、其衍生物和盐及其应用 |
| CN107353334B (zh) * | 2017-08-30 | 2020-02-07 | 四川大学 | 基于唾液富酪蛋白的仿生防龋多肽、其衍生物和盐及应用 |
| JP7266202B2 (ja) * | 2018-02-19 | 2023-04-28 | 株式会社ファンケル | 化粧料及び抗炎症剤 |
| WO2020056191A1 (en) | 2018-09-13 | 2020-03-19 | Eirion Therapeutics, Inc. | Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors |
| WO2021207164A1 (en) * | 2020-04-08 | 2021-10-14 | Amicrobe, Inc. | Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections |
| CA3191359A1 (en) * | 2020-09-08 | 2022-03-17 | John D. O'neill | Tissue-derived matrikine compositions and methods therefor |
| CN122535420A (zh) | 2023-09-15 | 2026-08-07 | 雷文斯治疗公司 | 用于颈部肌张力障碍的使用肉毒毒素的系列治疗 |
| CN122514358A (zh) | 2023-09-19 | 2026-08-04 | 雷文斯治疗公司 | 需要快速起效美容效果和更平滑皮肤外观的患者中的使用肉毒毒素的治疗 |
| WO2025072381A1 (en) | 2023-09-25 | 2025-04-03 | Revance Therapeutics, Inc. | Methods for determining influence of carrier peptide on the binding of a therapeutic protein to a cell membrane |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744166A (en) * | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
| US5670617A (en) * | 1989-12-21 | 1997-09-23 | Biogen Inc | Nucleic acid conjugates of tat-derived transport polypeptides |
| US5804604A (en) * | 1989-12-21 | 1998-09-08 | Biogen, Inc. | Tat-derived transport polypeptides and fusion proteins |
| JPH08501060A (ja) * | 1992-04-23 | 1996-02-06 | アレリックス バイオファーマスーティカルス インコーポレーテッド | ヘルペスウィルス感染症の治療 |
| EP0903408A3 (en) | 1992-08-21 | 2005-11-02 | Biogen, Inc. | Tat-derived transport polypeptide |
| CA2152373C (en) * | 1993-10-22 | 1998-12-15 | Michael Twist (Deceased) | Treatment of cytomegalovirus infection |
| DE69434535T2 (de) | 1993-12-28 | 2006-07-20 | Allergan, Inc., Irvine | Toxische Komponente der Botulinumtoxine zur Modulation cholinergisch kontrollierter Sekretionen |
| US6232295B1 (en) | 1994-10-12 | 2001-05-15 | Jon Faiz Kayyem | Cell-specific contrast agent and gene delivery vehicles |
| GB9508204D0 (en) * | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
| DE69637731D1 (de) * | 1995-08-23 | 2008-12-11 | Univ British Columbia | Antimikrobielle kationische peptide und methoden zu ihrer identifizierung |
| US6043218A (en) * | 1996-10-22 | 2000-03-28 | Medical University Of South Carolina | Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| GB9623051D0 (en) | 1996-11-06 | 1997-01-08 | Schacht Etienne H | Delivery of DNA to target cells in biological systems |
| CA2314267A1 (en) * | 1997-12-10 | 1999-06-17 | Washington University | Anti-pathogen system and methods of use thereof |
| CA2309555A1 (en) * | 1997-12-12 | 1999-06-24 | Adam Sampson-Johannes | Selective killing and diagnosis of p53+ neoplastic cells |
| CA2347828A1 (en) | 1998-10-27 | 2000-05-04 | Mayo Foundation For Medical Education And Research | Methods for enhancing wound healing |
| EP1137664A2 (en) | 1998-12-10 | 2001-10-04 | Washington University | Protein transduction system and methods of use thereof |
| CZ20012038A3 (cs) | 1998-12-23 | 2001-09-12 | Idea Ag | Zdokonalený přípravek pro topické, neinvazivní použití in vivo |
| US7056656B1 (en) * | 1999-01-25 | 2006-06-06 | University Of Medicine And Dentistry Of New Jersey | Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA |
| US20030236214A1 (en) * | 1999-06-09 | 2003-12-25 | Wolff Jon A. | Charge reversal of polyion complexes and treatment of peripheral occlusive disease |
| US7008924B1 (en) * | 1999-07-21 | 2006-03-07 | Amgen, Inc. | VGF fusion polypeptides |
| US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| US6544548B1 (en) * | 1999-09-13 | 2003-04-08 | Keraplast Technologies, Ltd. | Keratin-based powders and hydrogel for pharmaceutical applications |
| US6844324B1 (en) * | 1999-11-12 | 2005-01-18 | Massachusetts Institute Of Technology | Modular peptide mediated intracellular delivery system and uses therefore |
| US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
| US6670322B2 (en) * | 2000-06-01 | 2003-12-30 | Wisconsin Alumni Research Foundation | Method of targeting pharmaceuticals to motor neurons |
| US20030215412A1 (en) * | 2000-07-21 | 2003-11-20 | Essentia Biosystems, Inc. | Induction of hair growth with vascular endothelial growth factor |
| US20040220100A1 (en) * | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
| DK1301213T3 (en) | 2000-07-21 | 2017-03-27 | Revance Therapeutics Inc | MULTI-COMPONENT SYSTEMS FOR BIOLOGICAL TRANSPORT |
| US6696038B1 (en) * | 2000-09-14 | 2004-02-24 | Expression Genetics, Inc. | Cationic lipopolymer as biocompatible gene delivery agent |
| US20020127247A1 (en) * | 2000-11-17 | 2002-09-12 | Allergen Sales, Inc. | Modified clostridial neurotoxins with altered biological persistence |
| DE60233137D1 (de) | 2001-02-16 | 2009-09-10 | Univ R | Transporter mit beabstandeten arginin-teilchen |
| CA2446458A1 (en) * | 2001-05-09 | 2002-11-14 | Yale University | Toll/interleukin-1 receptor adaptor protein (tirap) |
| US7060498B1 (en) * | 2001-11-28 | 2006-06-13 | Genta Salus Llc | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| MXPA04005611A (es) * | 2001-12-11 | 2005-04-19 | Cellgate Inc | Reactivos y conjugados de transporte de guanidinio. |
| AU2003216389A1 (en) | 2002-02-21 | 2003-09-09 | Essentia Biosystems, Inc. | Induction of hair growth with vascular endothelial growth factor |
| US20030215395A1 (en) * | 2002-05-14 | 2003-11-20 | Lei Yu | Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
| JP4154218B2 (ja) * | 2002-11-27 | 2008-09-24 | 寛紀 高麗 | 新規抗菌性ポリペプチドとその利用 |
| US20060115480A1 (en) * | 2002-12-19 | 2006-06-01 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| IL153557A0 (en) * | 2002-12-19 | 2003-07-06 | Yitzchak Hillman | Antibodies and antagonists to antimicrobial peptides for the purpose of treating, inhibiting and preventing auto immune diseases |
| KR20050118669A (ko) * | 2003-02-01 | 2005-12-19 | 뉴랄랩 리미티드 | 가용성 ａ-베타에 대한 항체를 생성하기 위한 능동 면역화 |
| WO2004084805A2 (en) * | 2003-03-19 | 2004-10-07 | The J. David Gladstone Institutes | Acetylated tat polypeptides and methods of use thereof |
| US7125842B2 (en) * | 2003-04-07 | 2006-10-24 | Canbas Co. Ltd. | Anti-fungal compounds and methods of use |
| MXPA06002828A (es) * | 2003-09-12 | 2006-06-23 | Univ British Columbia | Efectores de determinacion de inmunidad innata. |
| JP2005120050A (ja) * | 2003-10-20 | 2005-05-12 | Toagosei Co Ltd | 新規抗菌性ペプチドとその利用 |
| BRPI0508440A (pt) * | 2004-03-03 | 2007-07-24 | Revance Therapeutics Inc | composições e métodos para diagnóstico tópico e transporte terapêutico |
| HUE025656T2 (en) * | 2004-03-03 | 2016-04-28 | Revance Therapeutics Inc | Topical application and transdermal delivery of botulinum toxins |
| DK1927597T3 (en) * | 2004-08-18 | 2017-02-13 | Novabiotics Ltd | ANTIBACTERIAL PEPTIDES |
| EP1656951A1 (en) * | 2004-11-12 | 2006-05-17 | Xigen S.A. | Conjugates with enhanced cell uptake activity |
| EP2116603A3 (en) | 2004-11-12 | 2010-02-17 | The University Of British Columbia | Antimicrobial peptides |
| EP1661912A1 (en) | 2004-11-29 | 2006-05-31 | Xigen S.A. | Fusion protein comprising a BH3-domain of a BH3-only protein |
| JP4730584B2 (ja) * | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
| JP2006238751A (ja) * | 2005-03-02 | 2006-09-14 | Toagosei Co Ltd | ベロ毒素結合性を有する抗菌ペプチド及びその利用 |
| ES2362301T3 (es) | 2005-03-03 | 2011-07-01 | Revance Therapeutics, Inc. | Composiciones y procedimientos para aplicaciones tópicas y liberación transdérmica de un oligopéptido. |
| KR20070110402A (ko) | 2005-03-03 | 2007-11-16 | 레반스 테라퓨틱스 | 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법 |
| WO2006105450A2 (en) | 2005-03-30 | 2006-10-05 | Revance Therapeutics, Inc. | Compositions and methods for treating acne |
| WO2007059528A2 (en) | 2005-11-17 | 2007-05-24 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| WO2008082889A2 (en) | 2006-12-29 | 2008-07-10 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat |
| NZ598159A (en) | 2006-12-29 | 2013-08-30 | Revance Therapeutics Inc | Transport molecules using reverse sequence hiv-tat polypeptides |
| DK2178549T3 (en) * | 2007-07-26 | 2017-01-09 | Revance Therapeutics Inc | Antimicrobial peptide AND COMPOSITIONS THEREOF |
| LT2379104T (lt) * | 2008-12-31 | 2018-04-10 | Revance Therapeutics, Inc. | Injekcinės botulino toksino vaisto formos |
-
2008
- 2008-07-28 DK DK08826608.5T patent/DK2178549T3/en active
- 2008-07-28 SI SI200831732T patent/SI2178549T1/sl unknown
- 2008-07-28 CA CA2694046A patent/CA2694046C/en active Active
- 2008-07-28 EP EP08826608.5A patent/EP2178549B1/en active Active
- 2008-07-28 PT PT88266085T patent/PT2178549T/pt unknown
- 2008-07-28 BR BR122019000266-5A patent/BR122019000266B1/pt active IP Right Grant
- 2008-07-28 KR KR1020157019647A patent/KR101717275B1/ko active Active
- 2008-07-28 NZ NZ582459A patent/NZ582459A/en unknown
- 2008-07-28 KR KR1020107003133A patent/KR101722038B1/ko active Active
- 2008-07-28 KR KR1020187007958A patent/KR102088949B1/ko active Active
- 2008-07-28 SG SG2013009832A patent/SG188128A1/en unknown
- 2008-07-28 PT PT161840947T patent/PT3120862T/pt unknown
- 2008-07-28 US US12/669,705 patent/US8623811B2/en active Active
- 2008-07-28 BR BRPI0813627-0A patent/BRPI0813627B1/pt active IP Right Grant
- 2008-07-28 EP EP20166266.5A patent/EP3741380A1/en active Pending
- 2008-07-28 PL PL08826608T patent/PL2178549T3/pl unknown
- 2008-07-28 ES ES08826608.5T patent/ES2609914T3/es active Active
- 2008-07-28 HU HUE08826608A patent/HUE031136T2/en unknown
- 2008-07-28 HR HRP20161722TT patent/HRP20161722T1/hr unknown
- 2008-07-28 ES ES16184094T patent/ES2805225T3/es active Active
- 2008-07-28 EP EP16184094.7A patent/EP3120862B1/en active Active
- 2008-07-28 WO PCT/US2008/071350 patent/WO2009015385A1/en not_active Ceased
- 2008-07-28 DK DK16184094.7T patent/DK3120862T3/da active
- 2008-07-28 JP JP2010518431A patent/JP5401457B2/ja not_active Expired - Fee Related
- 2008-07-28 CN CN201210375756.5A patent/CN102872447B/zh active Active
- 2008-07-28 MX MX2010000916A patent/MX2010000916A/es active IP Right Grant
- 2008-07-28 CN CN200880100641.7A patent/CN101842107B/zh active Active
- 2008-07-28 AU AU2008278593A patent/AU2008278593B2/en active Active
- 2008-07-28 BR BR122019000258-4A patent/BR122019000258B1/pt active IP Right Grant
- 2008-07-28 LT LTEP08826608.5T patent/LT2178549T/lt unknown
- 2008-07-28 KR KR1020177002763A patent/KR20170016031A/ko not_active Ceased
-
2010
- 2010-01-06 IL IL203173A patent/IL203173A/en active IP Right Grant
- 2010-01-27 CR CR11239A patent/CR11239A/es not_active Application Discontinuation
- 2010-02-26 CO CO10023449A patent/CO6260098A2/es not_active Application Discontinuation
-
2012
- 2012-12-20 IL IL223784A patent/IL223784A/en active IP Right Grant
- 2012-12-20 IL IL223785A patent/IL223785A/en active IP Right Grant
-
2013
- 2013-10-28 JP JP2013222846A patent/JP5965884B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-04 JP JP2016132290A patent/JP2017002057A/ja active Pending
- 2016-12-14 CY CY20161101296T patent/CY1118503T1/el unknown
-
2018
- 2018-08-17 JP JP2018153719A patent/JP6722241B2/ja active Active
-
2020
- 2020-06-19 JP JP2020105975A patent/JP2020169190A/ja active Pending
- 2020-07-27 CY CY20201100692T patent/CY1123176T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2011136981A5 (esLanguage) | ||
| JP2012034696A5 (esLanguage) | ||
| JP2007045829A5 (esLanguage) | ||
| JP2017048194A5 (esLanguage) | ||
| JP2013510581A5 (esLanguage) | ||
| WO2007149542A3 (en) | Antimicrobial kinocidin compositions and methods of use | |
| JP2011177189A5 (esLanguage) | ||
| WO2007122581A3 (en) | Compositions and kits of phenylephrine | |
| JP2009225798A5 (esLanguage) | ||
| NZ612161A (en) | Radiolabled her2 binding peptides | |
| JP2009504138A5 (esLanguage) | ||
| WO2008011335A3 (en) | Metal binding compounds, metal binding compositions, and their uses | |
| WO2013000922A9 (en) | Ccr2 antagonist peptides | |
| DE602005008996D1 (de) | Radiofluorierte peptide | |
| WO2008093058A3 (en) | Peptides and their use | |
| TW200942524A (en) | Novel aminomethyl benzene derivatives | |
| JP2015533791A5 (esLanguage) | ||
| WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
| JP2007510403A5 (esLanguage) | ||
| JP2014525439A5 (esLanguage) | ||
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| JP2012529293A5 (esLanguage) | ||
| JP2012211968A5 (esLanguage) | ||
| WO2010026219A3 (en) | New tomato ethylene response factors and uses thereof |